PERCEPTIVE ADVISORS LLC Holdings

PERCEPTIVE ADVISORS LLC is an investment fund managing more than 3.45B US dollars. The largest holdings include Amicus Therapeutics, Mirati Therapeutics and Cerevel Therapeutics Holdings. In Q3 2022 the fund bought assets of total value of 755.12M US dollars and sold assets of total value of 104.11M US dollars.

$3.44B

portfolio value

+16.50%

quarter

-45.74%

1 year

-52.24%

3 years

-71.78%

5 years

PERCEPTIVE ADVISORS LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	82972000	114121000
Q2 2016	300969000	121214000
Q3 2016	325874000	43270000
Q4 2016	238847000	317548000
Q1 2017	518324000	199509000
Q2 2017	462303000	282236000
Q3 2017	738917000	142717000
Q4 2017	736422000	286184000
Q1 2018	818234000	330822000
Q2 2018	522969000	305535000
Q3 2018	471405000	502292000
Q4 2018	366363000	1129598000
Q1 2019	951893000	294954000
Q2 2019	949006000	153309000
Q3 2019	105817000	562350000
Q4 2019	1032018000	309659000
Q1 2020	-101263000	682752000
Q2 2020	1041734000	24233000
Q3 2020	1281605000	784384000
Q4 2020	2559090000	24621000
Q1 2021	791306000	2226210000
Q2 2021	946110000	844056000
Q3 2021	633411000	1092316000
Q4 2021	1044100000	1160460000
Q1 2022	205768000	1126448000
Q2 2022	22307000	1453071000
Q3 2022	755119000	104114000

PERCEPTIVE ADVISORS LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Amicus Therapeutics, Inc. Portfolio share: 8.29% Portfolio value: 285.77M Avg. open price: $10.73 Current price: $12.37 P/L: +15.26% Bought +1.77% shares Q3 2022	share	8.29%	285.77M	$10.73	$12.37	+15.26%	Bought +1.77% shares Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 5.64% Portfolio value: 194.49M Avg. open price: $78.8 Current price: $92.75 P/L: +17.70% Sold -2.86% shares Q3 2022	share	5.64%	194.49M	$78.8	$92.75	+17.70%	Sold -2.86% shares Q3 2022
Biotechnology Cerevel Therapeutics Holdings, Inc. Portfolio share: 5.34% Portfolio value: 184.02M Avg. open price: $25.76 Current price: $28.31 P/L: +9.90% Bought +28.01% shares Q3 2022	share	5.34%	184.02M	$25.76	$28.31	+9.90%	Bought +28.01% shares Q3 2022
Biotechnology Global Blood Therapeutics, Inc. Portfolio share: 4.59% Portfolio value: 158.14M Avg. open price: $29.54 Current price: $68.49 P/L: +131.88% Sold -22.98% shares Q3 2022	share	4.59%	158.14M	$29.54	$68.49	+131.88%	Sold -22.98% shares Q3 2022
Biotechnology Amylyx Pharmaceuticals, Inc. Portfolio share: 4.47% Portfolio value: 154.03M Avg. open price: $15.95 Current price: $38.55 P/L: +141.74% Bought +54.56% shares Q3 2022	share	4.47%	154.03M	$15.95	$38.55	+141.74%	Bought +54.56% shares Q3 2022
Biotechnology LianBio Portfolio share: 3.34% Portfolio value: 115.11M Avg. open price: $2.46 Current price: $1.49 P/L: -39.45% Bought +1.76% shares Q3 2022	share	3.34%	115.11M	$2.46	$1.49	-39.45%	Bought +1.76% shares Q3 2022
Biotechnology CinCor Pharma, Inc. Portfolio share: 3.15% Portfolio value: 108.52M Avg. open price: $18.84 Current price: $12.33 P/L: -34.55% Bought +42.58% shares Q3 2022	share	3.15%	108.52M	$18.84	$12.33	-34.55%	Bought +42.58% shares Q3 2022
Biotechnology BELLUS Health Inc. Portfolio share: 3.14% Portfolio value: 108.20M Avg. open price: $9.13 Current price: $10.02 P/L: +9.73% Bought +85.16% shares Q3 2022	share	3.14%	108.20M	$9.13	$10.02	+9.73%	Bought +85.16% shares Q3 2022
Biotechnology Crinetics Pharmaceuticals, Inc. Portfolio share: 3.03% Portfolio value: 104.50M Avg. open price: $17.97 Current price: $18.32 P/L: +1.95% Bought +3.05% shares Q2 2022	share	3.03%	104.50M	$17.97	$18.32	+1.95%	Bought +3.05% shares Q2 2022
Biotechnology SpringWorks Therapeutics, Inc. Portfolio share: 2.87% Portfolio value: 99.01M Avg. open price: $54.64 Current price: $24.25 P/L: -55.62% Sold -10.26% shares Q3 2022	share	2.87%	99.01M	$54.64	$24.25	-55.62%	Sold -10.26% shares Q3 2022
Biotechnology Iovance Biotherapeutics, Inc. Portfolio share: 2.85% Portfolio value: 98.18M Avg. open price: $18.2 Current price: $8.03 P/L: -55.87% Sold -13.34% shares Q3 2022	share	2.85%	98.18M	$18.2	$8.03	-55.87%	Sold -13.34% shares Q3 2022
Biotechnology Relmada Therapeutics, Inc. Portfolio share: 2.56% Portfolio value: 88.23M Avg. open price: $18.99 Current price: $4.45 P/L: -76.57% Bought +1864.14% shares Q3 2022	share	2.56%	88.23M	$18.99	$4.45	-76.57%	Bought +1864.14% shares Q3 2022
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 2.52% Portfolio value: 86.65M Avg. open price: N/A Current price: $37.72 P/L: N/A Sold -12.71% shares Q3 2022	share	2.52%	86.65M	N/A	$37.72	N/A	Sold -12.71% shares Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 2.22% Portfolio value: 76.62M Avg. open price: $14.96 Current price: $38.83 P/L: +159.54% Sold -11.98% shares Q2 2022	share	2.22%	76.62M	$14.96	$38.83	+159.54%	Sold -11.98% shares Q2 2022
Biotechnology Aldeyra Therapeutics, Inc. Portfolio share: 1.76% Portfolio value: 60.60M Avg. open price: $5.82 Current price: $6.46 P/L: +10.92% Bought +14.60% shares Q3 2022	share	1.76%	60.60M	$5.82	$6.46	+10.92%	Bought +14.60% shares Q3 2022
Biotechnology MeiraGTx Holdings plc Portfolio share: 1.70% Portfolio value: 58.56M Avg. open price: $13.74 Current price: $6.49 P/L: -52.81% Bought +0.22% shares Q2 2022	share	1.70%	58.56M	$13.74	$6.49	-52.81%	Bought +0.22% shares Q2 2022
Biotechnology Inhibrx, Inc. Portfolio share: 1.50% Portfolio value: 51.83M Avg. open price: $23.31 Current price: $29.18 P/L: +25.21% Bought +50.83% shares Q3 2022	share	1.50%	51.83M	$23.31	$29.18	+25.21%	Bought +50.83% shares Q3 2022
Biotechnology Verona Pharma plc Portfolio share: 1.50% Portfolio value: 51.58M Avg. open price: $4.4 Current price: $13.57 P/L: +208.26% Bought +73.14% shares Q3 2022	share	1.50%	51.58M	$4.4	$13.57	+208.26%	Bought +73.14% shares Q3 2022
Biotechnology Cogent Biosciences, Inc. Portfolio share: 1.39% Portfolio value: 47.85M Avg. open price: $9.02 Current price: $12.5 P/L: +38.58% Bought +3.84% shares Q3 2022	share	1.39%	47.85M	$9.02	$12.5	+38.58%	Bought +3.84% shares Q3 2022
Biotechnology Arcellx, Inc. Portfolio share: 1.34% Portfolio value: 46.27M Avg. open price: $18.08 Current price: $19.45 P/L: +7.58% Bought +115.89% shares Q3 2022	share	1.34%	46.27M	$18.08	$19.45	+7.58%	Bought +115.89% shares Q3 2022
TRAVERE THERAPEUTICS INC Portfolio share: 1.33% Portfolio value: 45.98M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2022	share	1.33%	45.98M	N/A	N/A	N/A	N/A Q1 2022
Biotechnology Lyra Therapeutics, Inc. Portfolio share: 1.33% Portfolio value: 45.82M Avg. open price: $4.02 Current price: $3.39 P/L: -15.67% Bought +183.83% shares Q2 2022	share	1.33%	45.82M	$4.02	$3.39	-15.67%	Bought +183.83% shares Q2 2022
Biotechnology Albireo Pharma, Inc. Portfolio share: 1.33% Portfolio value: 45.69M Avg. open price: $24.35 Current price: $22.7 P/L: -6.76% Bought +20.41% shares Q3 2020	share	1.33%	45.69M	$24.35	$22.7	-6.76%	Bought +20.41% shares Q3 2020
Biotechnology Veru Inc. Portfolio share: 1.30% Portfolio value: 44.84M Avg. open price: $5.7 Current price: $5.82 P/L: +2.10% Bought +11.23% shares Q3 2022	share	1.30%	44.84M	$5.7	$5.82	+2.10%	Bought +11.23% shares Q3 2022
Biotechnology Relay Therapeutics, Inc. Portfolio share: 1.26% Portfolio value: 43.46M Avg. open price: N/A Current price: $18.36 P/L: N/A Sold -3.72% shares Q3 2021	share	1.26%	43.46M	N/A	$18.36	N/A	Sold -3.72% shares Q3 2021
Biotechnology Seagen Inc. Portfolio share: 1.26% Portfolio value: 43.31M Avg. open price: $176.94 Current price: $121.22 P/L: -31.49% Bought +41.31% shares Q3 2022	share	1.26%	43.31M	$176.94	$121.22	-31.49%	Bought +41.31% shares Q3 2022
Biotechnology RAPT Therapeutics, Inc. Portfolio share: 1.20% Portfolio value: 41.21M Avg. open price: $23.76 Current price: $16.53 P/L: -30.44% Sold -10.48% shares Q3 2022	share	1.20%	41.21M	$23.76	$16.53	-30.44%	Sold -10.48% shares Q3 2022
Biotechnology VBI Vaccines Inc. Portfolio share: 1.08% Portfolio value: 37.15M Avg. open price: $1.81 Current price: $0.49 P/L: -73.26% Sold -4.92% shares Q4 2021	share	1.08%	37.15M	$1.81	$0.49	-73.26%	Sold -4.92% shares Q4 2021
Medical Devices Treace Medical Concepts, Inc. Portfolio share: 1.03% Portfolio value: 35.35M Avg. open price: $14.34 Current price: $24.44 P/L: +70.43% Bought +70.21% shares Q3 2022	share	1.03%	35.35M	$14.34	$24.44	+70.43%	Bought +70.21% shares Q3 2022
Biotechnology Nuvalent, Inc. Portfolio share: 0.93% Portfolio value: 32.17M Avg. open price: $19.21 Current price: $34.16 P/L: +77.82% Sold -5.51% shares Q2 2022	share	0.93%	32.17M	$19.21	$34.16	+77.82%	Sold -5.51% shares Q2 2022
Medical Devices Establishment Labs Holdings Inc. Portfolio share: 0.92% Portfolio value: 31.57M Avg. open price: $33.35 Current price: $68.77 P/L: +106.18% Bought +42.51% shares Q3 2022	share	0.92%	31.57M	$33.35	$68.77	+106.18%	Bought +42.51% shares Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 0.83% Portfolio value: 28.52M Avg. open price: $82.87 Current price: $103.53 P/L: +24.93% Bought +86.93% shares Q3 2022	share	0.83%	28.52M	$82.87	$103.53	+24.93%	Bought +86.93% shares Q3 2022
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 0.81% Portfolio value: 27.96M Avg. open price: $34.63 Current price: $122.96 P/L: +255.06% N/A Q3 2022	share	0.81%	27.96M	$34.63	$122.96	+255.06%	N/A Q3 2022
Medical Devices Edwards Lifesciences Corporation Portfolio share: 0.79% Portfolio value: 27.26M Avg. open price: N/A Current price: $73.85 P/L: N/A N/A Q3 2022	share	0.79%	27.26M	N/A	$73.85	N/A	N/A Q3 2022
Biotechnology Zymeworks Inc. Portfolio share: 0.79% Portfolio value: 27.06M Avg. open price: $23.65 Current price: $7.62 P/L: -67.78% Bought +6.47% shares Q3 2022	share	0.79%	27.06M	$23.65	$7.62	-67.78%	Bought +6.47% shares Q3 2022
Biotechnology ADMA Biologics, Inc. Portfolio share: 0.77% Portfolio value: 26.56M Avg. open price: $3.86 Current price: $3.25 P/L: -15.85% Sold -5.10% shares Q3 2022	share	0.77%	26.56M	$3.86	$3.25	-15.85%	Sold -5.10% shares Q3 2022
Biotechnology Viridian Therapeutics, Inc. Portfolio share: 0.73% Portfolio value: 25.03M Avg. open price: $16.38 Current price: $26.84 P/L: +63.81% Bought +25.60% shares Q3 2022	share	0.73%	25.03M	$16.38	$26.84	+63.81%	Bought +25.60% shares Q3 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 0.73% Portfolio value: 25.02M Avg. open price: $34.06 Current price: $49.41 P/L: +45.05% Bought +14.04% shares Q3 2022	share	0.73%	25.02M	$34.06	$49.41	+45.05%	Bought +14.04% shares Q3 2022
Biotechnology Immatics N.V. Portfolio share: 0.73% Portfolio value: 25M Avg. open price: N/A Current price: $11.13 P/L: N/A N/A Q3 2020	share	0.73%	25M	N/A	$11.13	N/A	N/A Q3 2020
Health Information Services CareMax, Inc. Portfolio share: 0.70% Portfolio value: 24.07M Avg. open price: $6.18 Current price: $3.49 P/L: -43.56% Bought +13.16% shares Q3 2022	share	0.70%	24.07M	$6.18	$3.49	-43.56%	Bought +13.16% shares Q3 2022
Biotechnology Tarsus Pharmaceuticals, Inc. Portfolio share: 0.64% Portfolio value: 22.19M Avg. open price: N/A Current price: $16.74 P/L: N/A N/A Q4 2020	share	0.64%	22.19M	N/A	$16.74	N/A	N/A Q4 2020
Biotechnology Revance Therapeutics, Inc. Portfolio share: 0.63% Portfolio value: 21.83M Avg. open price: $21.38 Current price: $21.1 P/L: -1.33% Bought +41.25% shares Q3 2022	share	0.63%	21.83M	$21.38	$21.1	-1.33%	Bought +41.25% shares Q3 2022
Biotechnology Madrigal Pharmaceuticals, Inc. Portfolio share: 0.62% Portfolio value: 21.51M Avg. open price: $89.09 Current price: $72.87 P/L: -18.21% Sold -9.93% shares Q3 2022	share	0.62%	21.51M	$89.09	$72.87	-18.21%	Sold -9.93% shares Q3 2022
Biotechnology Nautilus Biotechnology, Inc. Portfolio share: 0.56% Portfolio value: 19.31M Avg. open price: $6.14 Current price: $1.76 P/L: -71.34% Bought +2.24% shares Q4 2021	share	0.56%	19.31M	$6.14	$1.76	-71.34%	Bought +2.24% shares Q4 2021
Medical Devices Cytek Biosciences, Inc. Portfolio share: 0.55% Portfolio value: 18.98M Avg. open price: N/A Current price: $12.33 P/L: N/A N/A Q3 2022	share	0.55%	18.98M	N/A	$12.33	N/A	N/A Q3 2022
Medical Devices Outset Medical, Inc. Portfolio share: 0.54% Portfolio value: 18.61M Avg. open price: $18.27 Current price: $21.42 P/L: +17.24% Bought +17.01% shares Q3 2022	share	0.54%	18.61M	$18.27	$21.42	+17.24%	Bought +17.01% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.54% Portfolio value: 18.55M Avg. open price: $5.42 Current price: $21.89 P/L: +303.89% Sold -50.47% shares Q3 2022	share	0.54%	18.55M	$5.42	$21.89	+303.89%	Sold -50.47% shares Q3 2022
Biotechnology Harmony Biosciences Holdings, Inc. Portfolio share: 0.53% Portfolio value: 18.23M Avg. open price: $33.27 Current price: $60.91 P/L: +83.05% N/A Q2 2022	share	0.53%	18.23M	$33.27	$60.91	+83.05%	N/A Q2 2022
Biotechnology Arcus Biosciences, Inc. Portfolio share: 0.51% Portfolio value: 17.43M Avg. open price: N/A Current price: $33.96 P/L: N/A N/A Q3 2022	share	0.51%	17.43M	N/A	$33.96	N/A	N/A Q3 2022
Biotechnology BridgeBio Pharma, Inc. Portfolio share: 0.49% Portfolio value: 16.86M Avg. open price: $71.11 Current price: $9.17 P/L: -87.10% Sold -55.80% shares Q2 2022	share	0.49%	16.86M	$71.11	$9.17	-87.10%	Sold -55.80% shares Q2 2022
Medical Devices Artivion, Inc. Portfolio share: 0.48% Portfolio value: 16.66M Avg. open price: $20.21 Current price: $13.31 P/L: -34.15% Bought +29.53% shares Q3 2022	share	0.48%	16.66M	$20.21	$13.31	-34.15%	Bought +29.53% shares Q3 2022
Biotechnology Coherus BioSciences, Inc. Portfolio share: 0.47% Portfolio value: 16.02M Avg. open price: $17.66 Current price: $6.74 P/L: -61.84% Sold -54.27% shares Q3 2022	share	0.47%	16.02M	$17.66	$6.74	-61.84%	Sold -54.27% shares Q3 2022
Biotechnology Verrica Pharmaceuticals Inc. Portfolio share: 0.43% Portfolio value: 14.71M Avg. open price: $8.53 Current price: $3.38 P/L: -60.36% Bought +39.57% shares Q2 2022	share	0.43%	14.71M	$8.53	$3.38	-60.36%	Bought +39.57% shares Q2 2022
Biotechnology Akero Therapeutics, Inc. Portfolio share: 0.42% Portfolio value: 14.64M Avg. open price: N/A Current price: $44.04 P/L: N/A N/A Q3 2022	share	0.42%	14.64M	N/A	$44.04	N/A	N/A Q3 2022
Biotechnology Concert Pharmaceuticals, Inc. Portfolio share: 0.42% Portfolio value: 14.40M Avg. open price: $12.55 Current price: $4.76 P/L: -62.07% Sold -2.00% shares Q4 2019	share	0.42%	14.40M	$12.55	$4.76	-62.07%	Sold -2.00% shares Q4 2019
Biotechnology Athira Pharma, Inc. Portfolio share: 0.41% Portfolio value: 14.24M Avg. open price: $17.34 Current price: $2.94 P/L: -83.04% Bought +40.03% shares Q2 2022	share	0.41%	14.24M	$17.34	$2.94	-83.04%	Bought +40.03% shares Q2 2022
Biotechnology Prothena Corporation plc Portfolio share: 0.40% Portfolio value: 13.94M Avg. open price: N/A Current price: $60.39 P/L: N/A N/A Q3 2022	share	0.40%	13.94M	N/A	$60.39	N/A	N/A Q3 2022
Biotechnology DICE Therapeutics, Inc. Portfolio share: 0.40% Portfolio value: 13.94M Avg. open price: $25.16 Current price: $34.51 P/L: +37.16% Sold -34.65% shares Q3 2022	share	0.40%	13.94M	$25.16	$34.51	+37.16%	Sold -34.65% shares Q3 2022
Biotechnology HilleVax, Inc. Portfolio share: 0.38% Portfolio value: 13.07M Avg. open price: N/A Current price: $17.5 P/L: N/A N/A Q2 2022	share	0.38%	13.07M	N/A	$17.5	N/A	N/A Q2 2022
Biotechnology Rain Therapeutics Inc. Portfolio share: 0.35% Portfolio value: 12.12M Avg. open price: N/A Current price: $6.83 P/L: N/A Sold -2.10% shares Q4 2021	share	0.35%	12.12M	N/A	$6.83	N/A	Sold -2.10% shares Q4 2021
Biotechnology Astria Therapeutics, Inc. Portfolio share: 0.34% Portfolio value: 11.58M Avg. open price: $5.08 Current price: $10.32 P/L: +103.15% Bought +0.71% shares Q1 2022	share	0.34%	11.58M	$5.08	$10.32	+103.15%	Bought +0.71% shares Q1 2022
Medical Devices AxoGen, Inc. Portfolio share: 0.33% Portfolio value: 11.32M Avg. open price: N/A Current price: $10.93 P/L: N/A N/A Q3 2022	share	0.33%	11.32M	N/A	$10.93	N/A	N/A Q3 2022
Medical Devices PROCEPT BioRobotics Corporation Portfolio share: 0.32% Portfolio value: 10.93M Avg. open price: $25.12 Current price: $45.58 P/L: +81.45% Sold -64.82% shares Q3 2022	share	0.32%	10.93M	$25.12	$45.58	+81.45%	Sold -64.82% shares Q3 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 0.31% Portfolio value: 10.62M Avg. open price: $57.87 Current price: $124 P/L: +114.29% Sold -74.85% shares Q3 2022	share	0.31%	10.62M	$57.87	$124	+114.29%	Sold -74.85% shares Q3 2022
Biotechnology Morphic Holding, Inc. Portfolio share: 0.30% Portfolio value: 10.27M Avg. open price: $33.55 Current price: $26.56 P/L: -20.83% Sold -52.67% shares Q2 2022	share	0.30%	10.27M	$33.55	$26.56	-20.83%	Sold -52.67% shares Q2 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 0.29% Portfolio value: 9.95M Avg. open price: $21.26 Current price: $51.99 P/L: +144.58% Sold -56.38% shares Q3 2022	share	0.29%	9.95M	$21.26	$51.99	+144.58%	Sold -56.38% shares Q3 2022
Biotechnology Landos Biopharma, Inc. Portfolio share: 0.28% Portfolio value: 9.66M Avg. open price: N/A Current price: $0.23 P/L: N/A N/A Q1 2021	share	0.28%	9.66M	N/A	$0.23	N/A	N/A Q1 2021
Biotechnology Larimar Therapeutics, Inc. Portfolio share: 0.27% Portfolio value: 9.15M Avg. open price: N/A Current price: $3.15 P/L: N/A N/A Q3 2022	share	0.27%	9.15M	N/A	$3.15	N/A	N/A Q3 2022
Medical Instruments & Supplies Singular Genomics Systems, Inc. Portfolio share: 0.26% Portfolio value: 8.84M Avg. open price: $11.36 Current price: $1.92 P/L: -83.10% Sold -3.25% shares Q2 2022	share	0.26%	8.84M	$11.36	$1.92	-83.10%	Sold -3.25% shares Q2 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 0.23% Portfolio value: 7.98M Avg. open price: $18.88 Current price: $19.03 P/L: +0.81% Sold -57.15% shares Q3 2022	share	0.23%	7.98M	$18.88	$19.03	+0.81%	Sold -57.15% shares Q3 2022
Biotechnology Kronos Bio, Inc. Portfolio share: 0.21% Portfolio value: 7.22M Avg. open price: N/A Current price: $1.77 P/L: N/A Sold -10.94% shares Q3 2022	share	0.21%	7.22M	N/A	$1.77	N/A	Sold -10.94% shares Q3 2022
Medical Devices IsoPlexis Corporation Portfolio share: 0.20% Portfolio value: 7.04M Avg. open price: N/A Current price: $1.29 P/L: N/A N/A Q4 2021	share	0.20%	7.04M	N/A	$1.29	N/A	N/A Q4 2021
Medical Devices Nevro Corp. Portfolio share: 0.20% Portfolio value: 6.99M Avg. open price: $85.74 Current price: $43.47 P/L: -49.30% N/A Q3 2022	share	0.20%	6.99M	$85.74	$43.47	-49.30%	N/A Q3 2022
Biotechnology C4 Therapeutics, Inc. Portfolio share: 0.20% Portfolio value: 6.72M Avg. open price: N/A Current price: $8.28 P/L: N/A Sold -63.21% shares Q2 2022	share	0.20%	6.72M	N/A	$8.28	N/A	Sold -63.21% shares Q2 2022
Biotechnology Leap Therapeutics, Inc. Portfolio share: 0.19% Portfolio value: 6.57M Avg. open price: $1.58 Current price: $0.52 P/L: -67.23% Sold -6.03% shares Q3 2022	share	0.19%	6.57M	$1.58	$0.52	-67.23%	Sold -6.03% shares Q3 2022
Biotechnology Solid Biosciences Inc. Portfolio share: 0.18% Portfolio value: 6.25M Avg. open price: $4.66 Current price: $6.46 P/L: +38.53% Bought +24.15% shares Q1 2021	share	0.18%	6.25M	$4.66	$6.46	+38.53%	Bought +24.15% shares Q1 2021
Biotechnology Revolution Medicines, Inc. Portfolio share: 0.18% Portfolio value: 6.12M Avg. open price: N/A Current price: $24.32 P/L: N/A N/A Q3 2022	share	0.18%	6.12M	N/A	$24.32	N/A	N/A Q3 2022
Diagnostics & Research Aclaris Therapeutics, Inc. Portfolio share: 0.16% Portfolio value: 5.37M Avg. open price: $25.53 Current price: $15.66 P/L: -38.66% Sold -10.96% shares Q2 2022	share	0.16%	5.37M	$25.53	$15.66	-38.66%	Sold -10.96% shares Q2 2022
Diagnostics & Research Natera, Inc. Portfolio share: 0.15% Portfolio value: 5.25M Avg. open price: N/A Current price: $40.39 P/L: N/A N/A Q3 2022	share	0.15%	5.25M	N/A	$40.39	N/A	N/A Q3 2022
Biotechnology Tricida, Inc. Portfolio share: 0.15% Portfolio value: 5.24M Avg. open price: N/A Current price: $0.23 P/L: N/A N/A Q3 2022	put	0.15%	5.24M	N/A	$0.23	N/A	N/A Q3 2022
Medical Devices Inari Medical, Inc. Portfolio share: 0.15% Portfolio value: 5.08M Avg. open price: $48.44 Current price: $71.11 P/L: +46.80% N/A Q3 2022	share	0.15%	5.08M	$48.44	$71.11	+46.80%	N/A Q3 2022
Medical Devices enVVeno Medical Corporation Portfolio share: 0.14% Portfolio value: 4.90M Avg. open price: N/A Current price: $5.93 P/L: N/A N/A Q4 2021	share	0.14%	4.90M	N/A	$5.93	N/A	N/A Q4 2021
Health Information Services Sema4 Holdings Corp. Portfolio share: 0.13% Portfolio value: 4.39M Avg. open price: $3.07 Current price: $0.38 P/L: -87.51% Bought +100.00% shares Q2 2022	share	0.13%	4.39M	$3.07	$0.38	-87.51%	Bought +100.00% shares Q2 2022
Health Information Services SomaLogic, Inc. Portfolio share: 0.13% Portfolio value: 4.35M Avg. open price: N/A Current price: $2.7 P/L: N/A Sold -26.83% shares Q4 2021	share	0.13%	4.35M	N/A	$2.7	N/A	Sold -26.83% shares Q4 2021
Biotechnology Tyra Biosciences, Inc. Portfolio share: 0.13% Portfolio value: 4.34M Avg. open price: N/A Current price: $6.89 P/L: N/A Sold -26.58% shares Q1 2022	share	0.13%	4.34M	N/A	$6.89	N/A	Sold -26.58% shares Q1 2022
Biotechnology CTI BioPharma Corp. Portfolio share: 0.12% Portfolio value: 4.27M Avg. open price: N/A Current price: $5.61 P/L: N/A N/A Q3 2022	share	0.12%	4.27M	N/A	$5.61	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Athenex, Inc. Portfolio share: 0.12% Portfolio value: 4.17M Avg. open price: $12.95 Current price: $0.19 P/L: -98.51% Bought +14.78% shares Q3 2022	share	0.12%	4.17M	$12.95	$0.19	-98.51%	Bought +14.78% shares Q3 2022
Biotechnology Acumen Pharmaceuticals, Inc. Portfolio share: 0.12% Portfolio value: 4.01M Avg. open price: N/A Current price: $5.6 P/L: N/A Sold -21.34% shares Q3 2022	share	0.12%	4.01M	N/A	$5.6	N/A	Sold -21.34% shares Q3 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 0.11% Portfolio value: 3.86M Avg. open price: N/A Current price: $6.72 P/L: N/A Sold -53.44% shares Q3 2022	share	0.11%	3.86M	N/A	$6.72	N/A	Sold -53.44% shares Q3 2022
Health Information Services Health Catalyst, Inc. Portfolio share: 0.11% Portfolio value: 3.78M Avg. open price: $41.36 Current price: $10.84 P/L: -73.79% Sold -16.17% shares Q3 2022	share	0.11%	3.78M	$41.36	$10.84	-73.79%	Sold -16.17% shares Q3 2022
Biotechnology Nanobiotix S.A. Portfolio share: 0.11% Portfolio value: 3.75M Avg. open price: N/A Current price: $3.83 P/L: N/A Sold -3.65% shares Q1 2021	share	0.11%	3.75M	N/A	$3.83	N/A	Sold -3.65% shares Q1 2021
COHERUS BIOSCIENCES INC Portfolio share: 0.10% Portfolio value: 3.59M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2021	share	0.10%	3.59M	N/A	N/A	N/A	N/A Q2 2021
Biotechnology Y-mAbs Therapeutics, Inc. Portfolio share: 0.09% Portfolio value: 3.05M Avg. open price: N/A Current price: $4.43 P/L: N/A N/A Q2 2022	share	0.09%	3.05M	N/A	$4.43	N/A	N/A Q2 2022
Biotechnology Pyxis Oncology, Inc. Portfolio share: 0.09% Portfolio value: 3.01M Avg. open price: N/A Current price: $1.29 P/L: N/A Sold -21.36% shares Q1 2022	share	0.09%	3.01M	N/A	$1.29	N/A	Sold -21.36% shares Q1 2022
Biotechnology Absci Corporation Portfolio share: 0.08% Portfolio value: 2.79M Avg. open price: N/A Current price: $2.4 P/L: N/A Sold -24.90% shares Q2 2022	share	0.08%	2.79M	N/A	$2.4	N/A	Sold -24.90% shares Q2 2022
Biotechnology Poseida Therapeutics, Inc. Portfolio share: 0.08% Portfolio value: 2.64M Avg. open price: N/A Current price: $5.1 P/L: N/A N/A Q3 2022	share	0.08%	2.64M	N/A	$5.1	N/A	N/A Q3 2022
Healthcare Plans Clover Health Investments, Corp. Portfolio share: 0.07% Portfolio value: 2.55M Avg. open price: N/A Current price: $1.26 P/L: N/A N/A Q1 2021	share	0.07%	2.55M	N/A	$1.26	N/A	N/A Q1 2021
Biotechnology Reata Pharmaceuticals, Inc. Portfolio share: 0.07% Portfolio value: 2.51M Avg. open price: N/A Current price: $39.62 P/L: N/A N/A Q3 2022	share	0.07%	2.51M	N/A	$39.62	N/A	N/A Q3 2022
Medical Devices Quotient Limited Portfolio share: 0.07% Portfolio value: 2.43M Avg. open price: $7.84 Current price: $0.73 P/L: -90.64% Bought +21.91% shares Q3 2020	share	0.07%	2.43M	$7.84	$0.73	-90.64%	Bought +21.91% shares Q3 2020
Health Information Services Science 37 Holdings, Inc. Portfolio share: 0.07% Portfolio value: 2.41M Avg. open price: N/A Current price: $0.61 P/L: N/A N/A Q4 2021	share	0.07%	2.41M	N/A	$0.61	N/A	N/A Q4 2021
Biotechnology Fulcrum Therapeutics, Inc. Portfolio share: 0.07% Portfolio value: 2.37M Avg. open price: $11.94 Current price: $6.56 P/L: -45.06% N/A Q2 2021	share	0.07%	2.37M	$11.94	$6.56	-45.06%	N/A Q2 2021
Biotechnology Travere Therapeutics, Inc. Portfolio share: 0.06% Portfolio value: 2.23M Avg. open price: $14.59 Current price: $20.01 P/L: +37.15% Sold -84.08% shares Q3 2022	share	0.06%	2.23M	$14.59	$20.01	+37.15%	Sold -84.08% shares Q3 2022
Health Information Services Pear Therapeutics, Inc. Portfolio share: 0.05% Portfolio value: 1.83M Avg. open price: N/A Current price: $1.96 P/L: N/A Sold -2.77% shares Q2 2022	share	0.05%	1.83M	N/A	$1.96	N/A	Sold -2.77% shares Q2 2022
Diagnostics & Research DarioHealth Corp. Portfolio share: 0.04% Portfolio value: 1.51M Avg. open price: N/A Current price: $4.82 P/L: N/A N/A Q1 2021	share	0.04%	1.51M	N/A	$4.82	N/A	N/A Q1 2021
Biotechnology Protara Therapeutics, Inc. Portfolio share: 0.02% Portfolio value: 859K Avg. open price: N/A Current price: $3.63 P/L: N/A Sold -24.37% shares Q2 2022	share	0.02%	859K	N/A	$3.63	N/A	Sold -24.37% shares Q2 2022
Medical Devices Hyperfine, Inc. Portfolio share: 0.02% Portfolio value: 751K Avg. open price: N/A Current price: $0.73 P/L: N/A Sold -18.25% shares Q3 2022	share	0.02%	751K	N/A	$0.73	N/A	Sold -18.25% shares Q3 2022
Medical Devices Sonendo, Inc. Portfolio share: 0.02% Portfolio value: 655K Avg. open price: N/A Current price: $2.63 P/L: N/A Sold -5.60% shares Q3 2022	share	0.02%	655K	N/A	$2.63	N/A	Sold -5.60% shares Q3 2022
Biotechnology Provention Bio, Inc. Portfolio share: 0.01% Portfolio value: 498K Avg. open price: $7.95 Current price: $8.94 P/L: +12.52% Sold -86.01% shares Q2 2022	share	0.01%	498K	$7.95	$8.94	+12.52%	Sold -86.01% shares Q2 2022
Biotechnology Icosavax, Inc. Portfolio share: 0.01% Portfolio value: 296K Avg. open price: N/A Current price: $3.19 P/L: N/A Sold -91.03% shares Q3 2022	share	0.01%	296K	N/A	$3.19	N/A	Sold -91.03% shares Q3 2022
Medical Devices Motus GI Holdings, Inc. Portfolio share: 0.01% Portfolio value: 221K Avg. open price: $4.24 Current price: $1.22 P/L: -71.25% N/A Q3 2022	share	0.01%	221K	$4.24	$1.22	-71.25%	N/A Q3 2022
Biotechnology EQRx, Inc. Portfolio share: 0.01% Portfolio value: 205K Avg. open price: N/A Current price: $0.5 P/L: N/A N/A Q4 2021	share	0.01%	205K	N/A	$0.5	N/A	N/A Q4 2021
Drug Manufacturers—Specialty & Generic Agile Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 158K Avg. open price: $1.9 Current price: $0.2 P/L: -89.25% N/A Q2 2022	share	0.00%	158K	$1.9	$0.2	-89.25%	N/A Q2 2022
CAREMAX INC Portfolio share: 0.00% Portfolio value: 113K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2021	share	0.00%	113K	N/A	N/A	N/A	N/A Q2 2021
Drug Manufacturers—Specialty & Generic Neptune Wellness Solutions Inc. Portfolio share: 0.00% Portfolio value: 87K Avg. open price: $2.37 Current price: $0.67 P/L: -71.89% N/A Q2 2022	share	0.00%	87K	$2.37	$0.67	-71.89%	N/A Q2 2022
Biotechnology Surrozen, Inc. Portfolio share: 0.00% Portfolio value: 31K Avg. open price: N/A Current price: $0.05 P/L: N/A N/A Q3 2021	share	0.00%	31K	N/A	$0.05	N/A	N/A Q3 2021
Biotechnology Surrozen, Inc. Portfolio share: 0.00% Portfolio value: 12K Avg. open price: N/A Current price: $0.54 P/L: N/A Sold -92.26% shares Q2 2022	share	0.00%	12K	N/A	$0.54	N/A	Sold -92.26% shares Q2 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $62.13 Current price: $226.4 P/L: +264.41% Sold -100.00% shares Q3 2022	share	0.00%	0	$62.13	$226.4	+264.41%	Sold -100.00% shares Q3 2022
Specialty Chemicals Zymergen Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.43 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.43	N/A	Sold -100.00% shares Q3 2022
Biotechnology MacroGenics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $22.88 Current price: $6.38 P/L: -72.11% Sold -100.00% shares Q3 2022	share	0.00%	0	$22.88	$6.38	-72.11%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $71.57 Current price: $369.29 P/L: +415.95% Sold -100.00% shares Q3 2022	share	0.00%	0	$71.57	$369.29	+415.95%	Sold -100.00% shares Q3 2022
Biotechnology Day One Biopharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $21.45 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$21.45	N/A	Sold -100.00% shares Q3 2022
Auto Manufacturers Ferrari N.V. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $223.68 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$223.68	N/A	Sold -100.00% shares Q3 2022
Biotechnology Cassava Sciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $62.08 Current price: $33.74 P/L: -45.65% Sold -100.00% shares Q3 2022	put	0.00%	0	$62.08	$33.74	-45.65%	Sold -100.00% shares Q3 2022
SPDR S&P Biotech ETF Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $85.64 Current price: $82.88 P/L: -3.22% Sold -100.00% shares Q3 2022	put	0.00%	0	$85.64	$82.88	-3.22%	Sold -100.00% shares Q3 2022
Health Information Services Privia Health Group, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $26.73 Current price: $23.52 P/L: -12.01% Sold -100.00% shares Q3 2022	share	0.00%	0	$26.73	$23.52	-12.01%	Sold -100.00% shares Q3 2022
Biotechnology Nuvation Bio Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.94 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.94	N/A	Sold -100.00% shares Q3 2022
Biotechnology Fusion Pharmaceuticals Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.36 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.36	N/A	Sold -100.00% shares Q3 2022
Medical Devices Motus GI Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $4.24 Current price: $1.22 P/L: -71.25% Sold -100.00% shares Q3 2022	share	0.00%	0	$4.24	$1.22	-71.25%	Sold -100.00% shares Q3 2022

Showing TOP 128 PERCEPTIVE ADVISORS's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of PERCEPTIVE ADVISORS LLC?

The biggest position of the PERCEPTIVE ADVISORS LLC is Amicus Therapeutics, Inc. (FOLD) with 8.29% portfolio share worth of 285.77M US dollars.

Top 5 PERCEPTIVE ADVISORS's holdings represent 28.34% of the portfolio:

Amicus Therapeutics, Inc. (FOLD) – 8.29%
Mirati Therapeutics, Inc. (MRTX) – 5.64%
Cerevel Therapeutics Holdings, Inc. (CERE) – 5.34%
Global Blood Therapeutics, Inc. (GBT) – 4.59%
Amylyx Pharmaceuticals, Inc. (AMLX) – 4.47%

Who is the portfolio manager of PERCEPTIVE ADVISORS LLC?

The portfolio manager of the PERCEPTIVE ADVISORS LLC is .

What is the total asset value of the PERCEPTIVE ADVISORS LLC portfolio?

PERCEPTIVE ADVISORS LLC total asset value (portfolio value) is 3.45B US dollars.

Who is ?

is the portfolio manager of the PERCEPTIVE ADVISORS LLC.

What is (PERCEPTIVE ADVISORS LLC) fund performance?

PERCEPTIVE ADVISORS's quarterly performance is +16.50%, annualy -45.74%. In the past 3 years, the value of 's portfolio has decreased by -52%. In the past 5 years, the value of the portfolio has decreased by -72%.

What is the PERCEPTIVE ADVISORS LLC CIK?

PERCEPTIVE ADVISORS's Central Index Key is 0001224962 .

PERCEPTIVE ADVISORS LLC Holdings

PERCEPTIVE ADVISORS LLC portfolio value:

PERCEPTIVE ADVISORS LLC quarter portfolio value change:

PERCEPTIVE ADVISORS LLC 1 year portfolio value change:

PERCEPTIVE ADVISORS LLC 3 years portfolio value change:

PERCEPTIVE ADVISORS LLC 5 years portfolio value change: